Peer Review History
Original SubmissionSeptember 12, 2020 |
---|
PONE-D-20-28761 Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson’s disease PLOS ONE Dear Dr. Ehlen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Allan Siegel Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information Additional Editor Comments: The present study was designed to determine whether electrical stimulation of the subthalamic nucleus (Sth) could reduce verbal errors that are associated with Parkinson’s disease (PD) in some patients. The study revealed two findings that are of interest and of potential significance. The first is that stimulation of the Sth could reduce verbal errors and the second suggested the possible presence of a functional localization within the Sth. A number of concerns were raised by the reviewers and editor and they are briefly summarized here. 1. One concern is the relatively small sample size which weakens confidence in some of the conclusions reached by the authors (e.g., the discussion of negative results which could be softened somewhat). 2. The timing of the delivery of medication relative to when the tests were administered was not clear and should be indicated in the Methods Section as well as the rationale for selection of that time period. 3. The properties and characteristics of the electrodes need to be specified and the reasons why bipolar and monopolar electrodes were used. Each has its own characteristics regarding the extent to which current is spread at the sites of stimulation. 4. The frequency of stimulation was not specified. Apparently, this could be an important variable since it has been shown that changes in the frequencies applied can significantly alter the observed effects. The authors should also indicate why the frequency they selected was chosen, 5. Statements regarding the extent of current spread and regions activated by stimulation are likely to be speculative. Much of this work was conducted in animals a number of decades ago and provided a good amount of information detailing the spread of current with reference to the type of electrode utilized and amount of current applied. The authors should go back into the literature and see if they can apply such findings to the present study. I believe that those animal studies were far more precise than those recently obtained in human studies. 6. It is better to describe the stimulation applied in current values. (i.e., � Amp values) than in voltage. 7. The issue of functional localization within the Sth could be important and more discussion should be given to this section. There is evidence that there are at least two type of neurons located in dorsal and ventral aspects of the Sth that are immunoreactive for calretinin and parvalbumin (see Emmi, et al., Neuroanat., 22 April 2020). Such information could be helpful in expanding and clarifying this aspect of the Discussion. Regarding the authors’ attempts to draw conclusions about functional localization within the Sth, this structure is relatively small. So how can we eliminate the possibility that stimulation non-specifically activates widespread regions of Sth so as to cast doubt on a functional localization hypothesis? Further discussion of this matter would be helpful. 8. Some analysis or discussion of whether the error rates were cognitive or motor should be presented. 9. It is not clear how comparisons with what appears to be a control condition were made relative to the effects of stimulation. Were they taken before or after? Were the conditions randomized or systematically altered? 10. VTA is a common abbreviation for the ventral tegmental area. You might want to change this abbreviation to avoid any confusion. 11. I didn’t see any separate section showing figure captions. If this correct, then it should be added to the paper. Other comments by both reviewers (not included above) are presumed to be included in this review and should be addressed as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present a nice, concise story of how STN DBS may affect language production in patients with Parkinson’s disease. They test patients with both stimulation on and off and see significant differences in word production, which correlates with VTA overlap of the associative region of the STN. Importantly, they also show that UPDRS change correlates better with VTA overlap of the motor STN, than associative, and that the reverse of these associations does not hold (no correlation with motor overlap and language and no correlation with associative overlap and UPDRS). My main concern is with the tone of the discussion on negative results. This is a very small sample of patients, so not finding an association is not proof that no association exists. Some sample language follows: “our results did not indicate a specific decrease in non-linguistic pauses and therefore rather argue for a general language acceleration.” “Further, the acceleration of language parameters was not explained by higher articulation rates, since these remained largely unchanged.” In both of these examples, there WERE differences, though they did not reach significance. That could either be because there is truly no association, or because the study is too small. So the authors need to soften their language—they shouldn’t make claims that are not statistically supported. Some other issues follow: p. 7: Did the authors control for timing of medication dosing between the two test periods? That is, if a patient was in an ON state following medication dosing while OFF DBS, vs. being in an OFF state while OFF DBS, that might change the results. p.7: There is no electrode model #3378. Do the authors mean 3387? p.8: The authors use a “heuristic” value (also known as “arbitrary” value) of 0.2 V/mm for defining their VTAs. Because their results depend so heavily on VTAs, they should do two things. One, provide references to support this choice. Two, perform a sensitivity analysis to see how much their results rely on this precise value, vs. being robust to an arbitrary choice like this. P.13 and 14: A lot of these metrics are inherently correlated. For example, if you say more words per second, you will (all else being equal) say more clauses per second. So it’s not surprising that the two are correlated. What doesn’t make sense to me is how articulation (syllables per second) and pauses are NOT significantly different, while word production IS significantly different. If the patients are not saying more syllables or taking shorter pauses, how are they getting more words out? I don’t see specifically how the data will be made available in the manuscript. This is a requirement for PLOS papers. Reviewer #2: This is a thoughtful and careful analysis of speech symptoms of STN DBS. I found it to be well done and well-written with very helpful analyses of effect sizes and limitations. I have some minor questions: 1) One of the largest effects was the error rate in Table 2. Was this a cognitive or motor phenotype? Could this be influenced by cognitive control? Line 267 - the Bonferroni correct was applied, but I'm not sure if the Ho can be supported or rejected... 2) On line 235, authors refer to multiple comparisons correction, but don't say how. Later, the refer to Bonferroni, and it appears that 14 tests were included here. I can't track how this was done and why. Bonferroni can over-correct, so I wonder if FDR is a more helpful approach. 3) Would the frequency of DBS have mattered for speech? There is data that low-frequency DBS can affect cognitive control (PMID: 29203130 / PMID: 29190362) or even timing (PMID: 21931767) - discussing these papers may help the authors argument. 4) VTA may be confused with the ventral tegmental area. I wonder if different acronym would be clearer. 5) Line 154 - I think the Edlow's reference MRI was postmortem - but when I read this, I thought the patients in the present study had died. Clarify? 6) Did the authors study speech intelligibility? 7) Line 322 - I don't know what the 'sense of' means here. What is the evidence that STN DBS patients are disinhibited - and evidence in this study? 8) 331 - here proposed is awkward 9) Line 389 - I would remove the word fully 10) Is Figure 2B cut off? The position of the label made me unsure 11) How many patients trajectories are plotted in Fig 1A and locations in Fig 1B? How does this link to the table? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson’s disease PONE-D-20-28761R1 Dear Dr. Ehlen, Both reviewers and myself agree that you and your team have addressed the questions raised and made all the appropriate changes in the manuscript. Accordingly, we are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Allan Siegel Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have addressed my concerns. No further issues have been identified. Everything looks ok for publication. Reviewer #2: I found the manuscript improved. I have no further comments. This will be an advance on our understanding of DBS. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: John Rolston Reviewer #2: No |
Formally Accepted |
PONE-D-20-28761R1 Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson’s disease Dear Dr. Ehlen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Allan Siegel Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .